Neuromyelitis optica without typical opticospinal phenotype

Multiple Sclerosis

Volumn 16, Issue 10, 2010, Pages 1154-1155

  Sato, Douglas ^a   Fujihara, Kazuo ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 4; AUTOANTIBODY; GADOLINIUM; IMMUNOGLOBULIN G; METHYLPREDNISOLONE;

ADULT; BRAIN; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG MEGADOSE; EDITORIAL; FEMALE; HUMAN; MYELOOPTIC NEUROPATHY; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; QUADRIPLEGIA; SPINAL CORD; SPINAL CORD DISEASE;

ADULT; AQUAPORIN 4; AUTOANTIBODIES; BRAIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROMYELITIS OPTICA; OPTIC NERVE; PHENOTYPE; SPINAL CORD;

EID: 77957573130     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458510377908     Document Type: Editorial

References (25)

1. Wingerchuk DM, Hogancamp WF, O'Brien PC and Weinshenker BG The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999 ; 53: 1107-1114.
2. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004 ; 364: 2106-2112.
3. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS and Hinson SR IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005 ; 202: 473-477.
4. Waters P. and Vincent A. Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays. Int MS J 2008 ; 15: 99-105.
5. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF and Weinshenker BG Revised diagnostic criteria for neuromyelitis optica. Neurology 2006 ; 66: 1485-1489.
6. Tanaka A., Yoshida T., Yamada T., et al. A case of cerebral aquaporinopathy. Mult Scler 2010 ; 00: 000-000.
7. Kim JS, Park YH, Kim SM, et al. A case of chronic progressive myelopathy. Mult Scler 2010 ; 00: 000-000.
8. Nozaki H., Shimohata T., Kanbayashi T., et al. A patient with anti-aquaporin 4 antibody who presented with recurrent hypersomnia, reduced orexin (hypocretin) level, and symmetrical hypothalamic lesions. Sleep Med 2009 ; 10: 253-255.
9. Baba T., Nakashima I., Kanbayashi T., et al. Narcolepsy as an intial manifestation of neuromyelitis optica with anti-aquaporin-4 antibody. J Neurol 2009 ; 256: 287-288.
10. Takahashi T., Miyazawa I., Misu T., et al. Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations. J Neurol Neurosurg Psychiatry 2008 ; 79: 1075-1078.
11. Thomson AJ, Montalban X., Barkhof F., et al. Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 2000 ; 47: 831-835. (Pubitemid 30390209)
12. Wingerchuk DM, Pittock SJ, Lucchinetti CF, Lennon VA and Weinshenker BG A secondary progressive clinical course is uncommon in neuromyelitis optica. Neurology 2007 ; 68: 603-605.
13. Pittock SJ, Lennon VA, Krecke K., Wingerchuk DM, Lucchinetti CF and Weinshenker BG Brain abnormalities in neuromyelitis optica. Arch Neurol 2006 ; 63: 390-396.
14. Misu T., Fujihara K., Nakamura M., et al. Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report. Tohoku J Exp Med 2006 ; 209: 269-275.
15. Roemer SF, Parisi JE, Lennon VA, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007 ; 130: 1194-1205.
16. Misu T., Fujihara K., Kakita A., et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007 ; 130: 1224-1234.
17. Misu T., Takano R., Fujihara K., Takahashi T., Sato S. and Itoyama Y. Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker. J Neurol Neurosurg Psychiatry 2009 ; 80: 575-577.
18. Hinson SR, Pittock SJ, Lucchinetti CF, et al. Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 2007 ; 69: 2221-2231.
19. Kinoshita M., Nakatsuji Y., Moriya M., et al. Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum. Neuroreport 2009 ; 20: 508-512.
20. Kinoshita M., Nakatsuji Y., Kimura T., et al. Neuromyelitis optica: passive transfer to rats by human immunoglobulin. Biochem Biophys Res Commun 2009 ; 386: 623-627.
21. Bennett JL, Lam C., Kalluri SR, et al. Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 2009 ; 66: 617-629.
22. Bradl M., Misu T., Takahashi T., et al. Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo. Ann Neurol 2009 ; 66: 630-643.
23. Kinoshita M., Nakatsuji Y., Kimura T., et al. Anti-aquaporin-4 antibody induces astrocytic cytotoxicity in the absence of CNS antigen-specific T cells. Biochem Biophys Res Commun 2010 ; 394: 205-210.
24. Carroll WM and Fujihara K. Neuromyelitis optica. Curr Treat Options Neurol, (in press).
25. Watanabe S., Nakashima I., Misu T., et al. Therapeutic efficacy of plasma exchange in NMO-IgG-positive patients with neuromyelitis optica. Mult Scler 2007 ; 13: 128-132. (Pubitemid 46152772)